Myomo Inc. (MYO) Stock Price

MYOStock

$1.48+17.80%52W

Market Cap$58.62M

P/E—

PEG Ratio—

Div yield—

Beta1.59

MYO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)66.50%

Price vs S&P 500 (4W)42.50%

VGM Score65.47

Book Value / Share (Quarterly)$0.15

P/TBV (Annual)3.56x

Revenue Growth (3Y)38.05%

Cash Flow / Share (Quarterly)$-0.23

Price vs S&P 500 (YTD)40.79%

Gross Margin (TTM)68.35%

Net Profit Margin (TTM)-33.53%

EPS (TTM)$-0.34

10-Day Avg Trading Volume0.92M

EPS Excl Extra (TTM)$-0.34

Revenue Growth (5Y)40.10%

EPS (Annual)$-0.37

ROI (Annual)-68.83%

Gross Margin (Annual)65.70%

Net Profit Margin (5Y Avg)-48.63%

Cash / Share (Quarterly)$0.34

Revenue Growth QoQ (YoY)21.26%

ROA (Last FY)-40.31%

Revenue Growth TTM (YoY)6.14%

EBITD / Share (TTM)$-0.25

ROE (5Y Avg)-97.63%

Operating Margin (TTM)-27.05%

Cash Flow / Share (Annual)$-0.46

P/B Ratio10.33x

P/B Ratio (Quarterly)6.89x

Net Income / Employee (Annual)$-80,300

EV / Revenue (TTM)1.41x

Net Interest Coverage (TTM)-21.58x

ROA (TTM)-40.07%

EPS Incl Extra (Annual)$-0.37

Current Ratio (Annual)3.30x

Quick Ratio (Quarterly)1.73x

3-Month Avg Trading Volume0.74M

52-Week Price Return17.80%

Revenue / Employee (TTM)$223,000

Tangible BV / Share (Quarterly)$0.10

P/S Ratio (Annual)1.47x

Asset Turnover (Annual)1.06x

52-Week High$1.89

Operating Margin (5Y Avg)-47.95%

EPS Excl Extra (Annual)$-0.37

CapEx CAGR (5Y)135.77%

Tangible BV CAGR (5Y)-12.57%

26-Week Price Return77.75%

Quick Ratio (Annual)2.69x

13-Week Price Return46.32%

Total Debt / Equity (Annual)0.98x

Current Ratio (Quarterly)2.31x

Enterprise Value$60.96M

Revenue / Share Growth (5Y)-15.56%

Asset Turnover (TTM)1.20x

Book Value / Share Growth (5Y)-34.81%

Revenue / Employee (Annual)$211,000

Inventory Turnover (Annual)4.46x

Pretax Margin (Annual)-36.82%

Cash / Share (Annual)$0.48

3-Month Return Std Dev133.74%

Gross Margin (5Y Avg)69.15%

Net Income / Employee (TTM)$-74,800

ROE (Last FY)-136.57%

Net Interest Coverage (Annual)-3.16x

EPS Basic Excl Extra (Annual)$-0.37

Receivables Turnover (TTM)7.21x

Total Debt / Equity (Quarterly)2.06x

EPS Incl Extra (TTM)$-0.34

Receivables Turnover (Annual)10.33x

ROI (TTM)-73.47%

P/S Ratio (TTM)1.39x

Pretax Margin (5Y Avg)-47.78%

Revenue / Share (Annual)$0.98

Tangible BV / Share (Annual)$0.26

Price vs S&P 500 (52W)-0.51%

Year-to-Date Return52.75%

5-Day Price Return-17.26%

EPS Normalized (Annual)$-0.37

ROA (5Y Avg)-53.59%

Net Profit Margin (Annual)-38.05%

Month-to-Date Return37.62%

Cash Flow / Share (TTM)$-0.32

EBITD / Share (Annual)$-0.32

Operating Margin (Annual)-35.19%

LT Debt / Equity (Annual)0.98x

ROI (5Y Avg)-84.08%

LT Debt / Equity (Quarterly)1.98x

EPS Basic Excl Extra (TTM)$-0.34

P/TBV (Quarterly)9.78x

P/B Ratio (Annual)3.07x

Inventory Turnover (TTM)3.75x

Pretax Margin (TTM)-32.52%

Book Value / Share (Annual)$0.30

Price vs S&P 500 (13W)43.52%

Beta1.59x

Revenue / Share (TTM)$1.01

ROE (TTM)-142.02%

52-Week Low$0.60

vGradeC

gGradeB

mGradeB

vgmGradeB

MYO Earnings Surprise History

Q2 25-0.11est. -0.11

Q3 25-0.09est. -0.11

Q4 25-0.09est. -0.09

Q1 26-0.09est. -0.12

Q2 26-0.07est. -0.10

MYO Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.00

Industry Peers — Orthopedic & Prosthetic Devices(33)

Symbol	Value Score	Growth Score	Momentum Score	Price
MYOMyomo Inc.	C	B	B	$1.48
ISRGIntuitive Surgical Inc.	D	B	D	$371.84
EWEdwards Lifesciences Corp	D	C	B	$90.87
STESTERIS plc	C	B	C	$236.44
ZBHZimmer Biomet Holdings, Inc.	B	C	C	$100.24
SNNSmith & Nephew plc	B	C	D	$29.22
ALGNAlign Technology Inc	B	D	C	$159.61
MSAMine Safety Incorporated	C	C	C	$187.69
ESTAEstablishment Labs Holdings Inc.	F	A	C	$72.15
ENOVEnovis Corporation	B	D	C	$25.58
CDRECadre Holdings, Inc.	C	C	C	$31.39
AVNSAvanos Medical, Inc.	B	D	C	$24.99
AVRAnteris Technologies Global Corp. Common Stock	F	D	B	$8.89
SMTISanara MedTech Inc. Common Stock	D	C	B	$34.67
ZJYLJIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares	B	D	C	$2.77
CNXUConexeu Sciences Inc. Common Stock	—	—	F	$7.55
INGNInogen Inc	B	D	D	$5.54
LAKELakeland Industries Inc	B	D	C	$11.52
SPAISafe Pro Group Inc. Common Stock	F	C	B	$5.25
NTRBNutriband Inc. Common Stock	F	D	B	$4.83
COCHEnvoy Medical, Inc. Class A Common Stock	D	D	C	$0.75
APTAlpha Pro Tech, Ltd.	A	D	C	$5.36
MLSSMilestone Scientific, Inc. Common Stock	D	D	B	$0.48
LFWDLifeward Ltd. Ordinary Shares	B	D	C	$7.39
RGNTRegentis Biomaterials Ltd.	—	—	C	$2.09
HSCSHeartSciences Inc. Common Stock	F	F	B	$3.00
CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares	—	D	C	$2.92
CLGNCollPlant Biotechnologies Ltd Ordinary Shares	C	F	F	$0.29
FEEDENvue Medical, Inc. Common Stock	A	F	F	$0.39
BBLGBone Biologics Corp Common Stock	—	—	F	$0.60
BBLGWBone Biologics Corp Warrants	—	—	D	$8.24
COCHWEnvoy Medical, Inc Warrant	—	—	F	$0.04
HSCSWHeartSciences Inc. Warrant	—	—	F	$0.04
NTRBWNutriband Inc. Warrant	—	—	D	$0.50

About Myomo Inc.

Myomo Inc manufactures MyoPro, an FDA-cleared Class II myoelectric orthosis designed to restore upper limb function in patients with neuromuscular disorders. The company distributes through orthotics and prosthetics providers worldwide and the Veterans Health Administration, while generating revenue through direct insurance billing for patient usage.